B. Müller‐Oerlinghausen

The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry

Pierre Baumann, Christoph Hiemke, S. Ulrich et al. · Pharmacopsychiatry · 2004 · 410 citations

The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry

I. Gaertner, Pierre Baumann, Christoph Hiemke et al. · Pharmacopsychiatry · 2005 · 343 citations

Psychiatric Evaluation, Psychotropic Medication, Psychopharmacology +20

Lithium versus carbamazepine in the maintenance treatment of bipolar disorders – a randomised study

W. Greil, Wolfgang Ludwig‐Mayerhofer, N. Erazo et al. · Journal of Affective Disorders · 1997 · 262 citations

Psychiatry, Psychotropic Medication, Lithium Versus Carbamazepine +12

Physicians' knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions

Joerg Hasford, M. Goettler, K.-H. Munter et al. · Journal of Clinical Epidemiology · 2002 · 224 citations

Drug Safety, Drug Hypersensitivity, Spontaneous Reporting System +8

Effect of Prophylactic Treatment on Suicide Risk in Patients with Major Affective Disorders

K. Thies-Flechtner, B. Müller‐Oerlinghausen, Wilda Seibert et al. · Pharmacopsychiatry · 1996 · 209 citations

Psychological Co-morbidities, Recent Findings, Mental Health +19